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Abstract 
Background: Since esophageal cancer is highly prevalent, and has a high cost for patients and society, this 
study aimed to investigate the result of surgery in esophageal cancer with esophagogastrostomy method to 
lower the problems of these patients. 
Methods: In this cross-sectional study, all patients who were diagnosed with esophageal and upper gastric cancer 
with surgical indications during 2004 to 2011 in Shahid Beheshti hospital, Babol City, Iran, participated. Patients then 
underwent esophagogastrostomy surgery. Patients’ data were gathered using a survey and analyzed using t and chi-
square tests via SPSS software. A P-value of less than 0.05 was deemed statistically significant. 
Results: A total of 47 patients who were confirmed as having esophageal cancer by pathologic evaluation, 
were investigated. A significant relationship was observed between body mass index and complications after 
surgery (P = 0.04). 57.1% of underweight patients and 100% of obese patients experienced complications. No 
significant relationship was seen in other factors. The average age of patients who experienced complications 
was higher than those who reported no complications, and the difference was statistically significant (P = 0.03). 
Moreover, the duration of surgery was significantly higher in patients with complications (P = 0.01). 
Conclusions: It would seem that complications after surgery were higher in underweight patients and the 
duration of surgery was higher in these patients. No significant relationship was seen in other factors. 
© 2018 Tehran University of Medical Sciences. All rights reserved. 
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Introduction 
Esophageal cancer is the seventh cause of death by 
cancer in the world. It affects over 450 thousand people 
per annum, and its prevalence is rapidly rising (1,2). 
Esophageal cancer is also highly prevalent in Iran, in a 
way that in a ten-year study estimating the occurrence 
of cancer from 1969 to 1978, it was considered the 
most prevalent type of cancer (3). In Turkmen Sahra 
regions, the occurrence rate is 108.8 per hundred 
thousand and 174.1 per hundred thousand per year in 
men and women, respectively. Surgery is considered 
the main treatment in patients who have no 
limitations/complications for surgery (4).  
The general survival rate for esophageal cancer 
patients varies between 15% to 25% in 5 years, and 
diagnosis in primary stages is beneficial to the 
treatment (5). Many varied methods of surgery are 
available for patients with esophageal cancer and upper 
stomach cancer. Choosing surgery as treatment for 
esophageal carcinoma depends on the anatomical stage 
of illness, the patients' ability to ingest, and the primary 
position of the tumor (6,7).  
This study evaluated left thoracotomy accompanied 
by esophagogastrostomy technique using a tongue-
shaped seromuscular flap as a method of surgery. The 
use of a tongue-shaped seromuscular flap is a method 
used in the presence of anastomosis in the thorax, in 
order to protect the anastomosis, lower the possibility of 
anastomotic leaks, and lessen the severe subsequent 
complications (8,9). The death rate of esophageal 
resection has significantly decreased within the last two 
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decades and reached under 10% (1,10). This disease is 
highly prevalent and treatment is expensive for patients 
and society; this study aimed to investigate the result of 
surgery in esophageal cancer with esophagogastrostomy 
method to lower the problems of these patients. 
 
Materials and Methods 
In this cross-sectional study, all patients who were 
diagnosed with esophageal and upper gastric cancer 
with surgical indications during 2004 to 2011 in Shahid 
Beheshti hospital, Babol City, Iran, participated. All 
patients were first examined by a thorax surgeon, their 
stage of cancer diagnosed, and evaluated for the 
existence of metastasis and cardiopulmonary problems 
which prevented surgery. Then, patients underwent left 
thoracotomy and esophagogastrostomy surgery using a 
tongue-shaped seromuscular flap.  
Patients’ data were gathered using a survey. The 
survey included age, gender, weight, period of weight 
loss, body mass index (BMI), surgical complications 
(up to a month), duration of surgery, hemoglobin 
levels, albumin levels, start of oral nutrition, and 
location and type of tumor.  
Data were analyzed using t and chi-square tests via 
SPSS software (version 22, IBM Corporation, Armonk, 
NY, United States). A P-value of less than 0.05 was 
deemed statistically significant.  
 
Results 
A total of 47 patients who were confirmed as having 
esophageal cancer by pathologic evaluation, were 
evaluated. Demographic data of these patients is presented 
in table 1.  
 
Table 1. The demographic data of studied patients 
Variable Number (%) 
Gender  
Male 31 (65.9) 
Female 16 (34.1) 
Age group   
50-70 years 32 (68.1) 
71-90 years 15 (31.9) 
Body mass index (BMI)  
Underweight 7 (14.9) 
Normal 32 (68.1) 
Overweight 7 (14.9) 
Obese 1 (2.1) 
Background illness 3 (6.4) 
Tumor location  
Distal 23 (48.9) 
Middle 10 (21.3) 
Cardia 14 (29.8) 
Diagnosis  
Squamous cell carcinoma 33 (70.2) 
Adenocarcinoma 14 (29.8) 
Postoperative complications  
Cardiac 7 (14.9) 
Pulmonary 4 (8.5) 
Neurological 2 (4.3) 
Cardiopulmonary 3 (6.4) 
In table 2, the mean and standard deviation (SD) for 
the studied quantitative variables is presented in detail.  
 
Table 2. The mean and standard deviation of quantitative 
variables 
Variable Value
*
 Range 
Age (year) 66.26 ± 7.27 50-84 
Weight (kg) 59.62 ± 9.59 43-80 
Weight loss (kg) 6.89 ± 3.68 0-20 
Length of weight loss (day) 3.72 ± 2.24 0-16 
Hemoglobin (g/dl) 12.50 ± 1.71 7.3-15.4 
Albumin (g/dl) 4.15 ± 0.46 3.23-5.87 
Duration of surgery (minute) 168.30 ± 23.22 90-225 
Start of oral nutrition (day) 5.38 ± 0.64 4-8 
Hospitalization (day) 8.02 ± 1.67 6-15 
* The amounts are presented as mean ± standard deviation. 
 
A significant relationship was observed between 
BMI and complications after surgery (P = 0.04). 57.1% 
of underweight patients and 100% of obese patients 
experienced complications. No significant relationship 
was seen in other factors (Table 3).  
 
Table 3. The relationship between studied variables and 
postoperative complications 
Variable Postoperative 
complications 
P-value 
Yes No 
Gender   0.77 
Male 11 (35.5) 20 (64.5)  
Female 5 (31.3) 11 (68.8)  
Age group   0.32 
50-70 years 9 (28.1) 23 (71.9)  
71-90 years 7 (46.7) 8 (53.3)  
Body mass index (BMI)   0.04 
Underweight  4 (57.1) 3 (42.9)  
Normal 11 (34.4) 21(65.6)  
Overweight - 7 (100)  
Obese 1 (100) -  
Diagnosis   0.32 
Squamous cell carcinoma  13 (39.4) 20 (60.6)  
Adenocarcinoma 3 (21.4) 11 (78.6)  
Tumor location   0.37 
Distal 10 (43.5) 13 (56.5)  
Middle 3 (30) 7 (70)  
Cardia 3 (21.4) 11 (78.6)  
The amounts are presented as number (percent). 
 
The average age of patients who experienced 
complications was higher than those who reported no 
complications, and the difference was statistically 
significant (P = 0.03). Moreover, the duration of 
surgery was significantly higher in patients with 
complications (P = 0.01) (Table 4). 
 
Discussion 
The highest reported occurrence rate for esophageal 
cancer in the world is attributed to a report from the 
Caspian Sea cancer center in 1973.  
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Table 4. The differences between postoperative complications and different variables. 
Variable Postoperative complications P-value 
Yes No 
Age (year) 69.44 ± 6.61 64.61 ± 7.14 0.03 
Weight (kg) 55.94 ± 9.68 61.52 ± 9.12 0.06 
Weight loss (kg) 7.13 ± 3.26 6.77 ± 3.93 0.76 
Length of weight loss (day) 4.13 ± 3.42 3.52 ± 1.13 0.38 
Hemoglobin (g/dl) 12.75 ± 1.09 12.40 ± 1.96 0.54 
Albumin (g/dl) 4.20 ± 0.44 4.13 ± 0.47 0.62 
Duration of surgery (minute) 180.00 ± 21.21 162.26 ± 22.16 0.01 
Start of oral nutrition (day) 5.56 ± 0.81 5.29 ± 0.52 0.19 
Hospitalization (day) 8.53 ± 2.12 7.73 ± 1.31 0.17 
The amounts are presented as mean ± standard deviation. 
 
The report states that the occurrence rate for 
esophageal cancer in the over-35-year age group was 
165.5 and 195.3 per hundred thousand in Gonbad, Iran 
for men and women, respectively (11). However, only 
a small part of cancer-related research has been 
dedicated to this field.  
In this study, patients with different extreme BMIs, 
underweight and obese, suffered more postoperative 
complications. Moreover, patients who went through 
postoperative complications had a higher age average 
in comparison to other patients. The duration of 
surgery significantly affected patients with 
postoperative complications. 63.8% of patients were 
without complications and 36.2% experienced 
postoperative complications. In another study 
performed by Nikbakhsh et al. comparing transhiatal 
and right transthoracic surgeries, the rates of 
complications were 42.9% and 47.1%, respectively (12). 
Similar studies performed by Connors et al. on 17395 
patients (13), Goan et al. on 216 patients (14), Chou et 
al. on 73 patients (15) have not found any significant 
differences. In a study performed by Gockel et al. on 424 
patients (16) and a meta-analysis by Hulscher et al. (17), 
the complications following transthoracic surgery were 
reported to be significantly more common than 
complications following transhiatal surgery.  
Among postoperative complications, cardiovascular 
complications rank first and make up 21.3% of the 
total. However, in the study performed by Nikbakhsh 
et al. pulmonary complications and anastomosis 
leakage reported to be the most common complications 
(12). Based on the results obtained from a study carried 
out by Jensen et al. on 166 patients with esophageal 
cancer who had undergone transthoracic surgery, 
pulmonary complications were the most prevalent 
complications (18). However, this is in contrast with 
the results obtained in our study. 
In the current study, it was observed that 
esophageal cancer was more prevalent in men. 
Postoperative complications were also higher in men. 
However, this factor was not statistically significant, 
and esophageal cancer is prevalent in both genders 
(19). In this study, the incidence ratio of men to women 
was 1.9 to 1. In a study performed by Rajaeifard et al. 
the gender ratio for esophageal cancer was reported to 
be 1.6 to 1 (men to women) (20). Gender ratio for 
esophageal cancer factor was reported to be 0.85% in 
Gonbad, Iran (11), 1% in the south east of the Caspian 
Sea (21), 1.04% in Babol, Iran (3), 1.5% in Imam 
Khomeini hospital, Tehran, Iran (4), 1.36% in Golestan 
Province, Iran (22), 1.4% in Pakistan (23), 1% in 
Uzbekistan (24), 1.5% in Kenya (25), 1.4% in China 
(26), 3% in Lithuania (27), 4.6% in Europe (28), and 
2.4% in white Americans. A possible explanation for 
this difference may be geographical differences.  
In this study, patients were mainly over the age of 
50 and under 70 years. The 50-70-year age group was 
most at risk for postoperative complications, even 
though no significant relationship was found. The age 
average in this study was higher in the postoperative 
complication group, which was not statistically 
significant. The frequency of disease and illness in old 
age, along with lowered capabilities, signs, and 
symptoms are missed which may be a possible 
explanation for the late diagnosis of esophageal cancer. 
However, it seems that the age for esophageal cancer 
has decreased in Iran. 
48.9% of tumors were located in the distal region of 
the esophagus in our study, and in a study performed 
by Rajabi et al., 71.7% of tumors were located in the 
aforementioned region (29). The locations of tumors in 
this study are in accordance with the study performed 
by Nikbakhsh et al. (12). 
In regards with histology, squamous cell carcinoma 
was observed in 70.2% of cases. So, tumor histology in 
this study is similar to the study performed by 
Rajaeifard et al. (20). Furthermore, in patients who 
experienced postoperative complications, histological 
reports showed that 81.3% of cases showed squamous 
cell carcinoma. In the study performed by Rajabi et al., 
tumor histology showed squamous cell carcinoma and 
adenocarcinoma in 76.7% and 23.3% of cases, 
respectively (29). 
The average duration of surgery was  
168.30 ± 23.22 minutes in this study. Duration of 
surgery in the study by Nikbakhsh et al. was 180 and 
226 minutes for transhiatal and transthoracic surgeries, 
respectively (12). 
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The limitations of this study are the lack of a control 
group, and that the survival rate was not considered. 
 
Conclusion 
It would seem that postoperative complications were 
higher in underweight patients, and the duration of 
surgery was also higher in these cases. No significant 
relationship was seen in other factors. 
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